Targeted Therapies in Neoadjuvant Treatment for Gastroesophageal Cancer

Abstract excerpt

Gastroesophageal cancers, are among the most prevalent cancers globally and represent the third leading cause of cancer-related mortality worldwide. Surgical resection remains the primary curative approach for localized and locally advanced stages, but its effectiveness is limited for locally advanced diseases, evidenced by a low 5-year survival rate of around 25%. High relapse rates post-surgery, particularly in...

Topics

Open a Topic to create a Post that cites this publication.

• Angiogenesis Inhibitors
• Esophageal Neoplasms
• Molecular Diagnostic Techniques
• Molecular Targeted Therapy
• Precision Medicine
• Proto-Oncogene Proteins c-met
• Receptor, ErbB-2
• Receptors, Vascular Endothelial Growth Factor

Identifiers and source

Literature Corpus work

4b55af58-a705-5bbd-9fc8-ecd46f37512b

DOI

10.20944/preprints202408.1165.v1